$Hong Kong Exchanges and Clearing(00388)$ Hong Kong IPO market gets boost as mainland China, US tighten grip on listings https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/hong-kong-ipo-market-gets-boost-as-mainland-china-us-tighten-grip-on-listings-65605444
$WUXI BIO(02269)$$WuXi AppTec(02359)$$TIGERMED(03347)$fast growing CRO business in China and expanding globally. https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/chinese-drug-contract-research-companies-see-surge-in-domestic-demand-63832298
$ADMA Biologics(ADMA)$FDA has granted approval for its expanded manufacturing process, enabling fractionation and purification of a 4,400-liter plasma pool for the manufacture of Intravenous Immune Globulin (IVIG).